Ocugen to Host Conference Call on Friday, February 25 at 8:30 a.m. ET to Discuss Fourth Quarter and Full Year 2021 Financial Results and Provide Business UpdateGlobeNewsWire • 02/18/22
Ocugen, Inc. Announces U.S. FDA Lifts Clinical Hold on the Submission of Its Investigational New Drug Application for Its COVID-19 Vaccine Candidate COVAXIN™ (BBV152)GlobeNewsWire • 02/18/22
4 Under-the-Radar Stocks With 319% to 645% Upside in 2022, According to Wall StreetThe Motley Fool • 01/29/22
Ocugen, Inc. Signs Letter of Intent to Acquire Vaccine Manufacturing, R&D Hub in Ontario, CanadaGlobeNewsWire • 01/27/22
Ocugen Inc. Announces Nirdosh Jagota, Ph.D. as Senior Vice President, Regulatory Affairs, Compliance & SafetyGlobeNewsWire • 01/24/22
Ocugen, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire • 01/21/22